pharma · Advanced Or Metastatic Merkel Cell Carcinoma · Cutaneous Melanoma, Stage III · HURA
TuHURA Biosciences, Inc./NV
TuHURA Biosciences, Inc./NV patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 1996
- Employees
- 32
- Programs
- 4
- Drugs
- 0
- Patents
- 0
TuHURA Biosciences, Inc./NV patents
0 pharmaceutical patents indexed for TuHURA Biosciences, Inc./NV. 0 expire within 24 months.
TuHURA Biosciences, Inc./NV has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does TuHURA Biosciences, Inc./NV have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do TuHURA Biosciences, Inc./NV patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.